Literature DB >> 15573934

Colitic cancer developed after introduction of azathioprine.

Jun-ichi Sasaki, Yutaka J Kawamura, Fumio Konishi, Tsutomu Tosha.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15573934     DOI: 10.1023/b:ddas.0000043393.67919.fe

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  18 in total

Review 1.  The unsolved problem of surveillance for colorectal cancer in ulcerative colitis.

Authors:  F Delcò; A Sonnenberg
Journal:  Can J Gastroenterol       Date:  1999-10       Impact factor: 3.522

2.  Colorectal cancer in inflammatory bowel disease: a continuing problem.

Authors:  R Mayer; W D Wong; D A Rothenberger; S M Goldberg; R D Madoff
Journal:  Dis Colon Rectum       Date:  1999-03       Impact factor: 4.585

Review 3.  Malignancies in inflammatory bowel disease: fact or fiction?

Authors:  R A van Hogezand; R F Eichhorn; A Choudry; R A Veenendaal; C B H W Lamers
Journal:  Scand J Gastroenterol Suppl       Date:  2002

4.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

5.  [Rapidly progressive irradiated cervical cancer that metastasized to the liver during therapy for idiopathic thrombocytopenic purpura].

Authors:  T Yoshimura; Y Tamai; H Takami; K Kariya; R Nakahata; K Tsushima; A Munakata; S Kawamura
Journal:  Rinsho Ketsueki       Date:  1999-02

6.  Rectal lymphoma in ulcerative colitis treated with azathioprine.

Authors:  C W Tan; G E Wilson; J M Howat; D R Shreeve
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-08       Impact factor: 2.566

7.  Ulcerative colitis and malignancy.

Authors:  K Geboes
Journal:  Acta Gastroenterol Belg       Date:  2000 Jul-Sep       Impact factor: 1.316

Review 8.  Cancer and inflammatory bowel disease: bias, epidemiology, surveillance, and treatment.

Authors:  M J Solomon; M Schnitzler
Journal:  World J Surg       Date:  1998-04       Impact factor: 3.352

9.  Assay of thioinosinic acid, an active metabolite of azathioprine, in human lymphocytes.

Authors:  L Fletcher; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

10.  Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease.

Authors:  W R Connell; M A Kamm; M Dickson; A M Balkwill; J K Ritchie; J E Lennard-Jones
Journal:  Lancet       Date:  1994-05-21       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.